Results 121 to 130 of about 15,495 (203)

BLCA-RegMap portal: a co-regulatory influence network view of bladder cancer heterogeneity

open access: yes, 2022
Introduction: Bladder cancer studies performed in a variety of laboratories and by anumber of large-scale projects have given an unparalleled amount of information on tumors and in vitro models. Consolidating these data into an easily accessible and comprehensive system-level format is crucial to accelerate systems oncology model development.Methods ...
Pawlak, Geoffrey   +4 more
openaire   +1 more source

SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer

open access: yesCell & Bioscience
Background Aberrant interplay between epigenetic reprogramming and metabolic rewiring events contributes to bladder cancer progression and metastasis.
Xiaojing Wang   +6 more
doaj   +1 more source

Characterization of cancer-related fibroblasts in bladder cancer and construction of CAFs-based bladder cancer classification: insights from single-cell and multi-omics analysis

open access: yesFrontiers in Immunology
BackgroundBladder cancer (BLCA) continues to be a significant cause of cancer mortality in the urinary tract, with therapeutic resistance representing a major barrier to improving patient outcomes.
Zhaokai Zhou   +10 more
doaj   +1 more source

TAZ/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis

open access: yesCell Death Discovery
Bladder cancer (BLCA) is a prevalent malignancy characterized by high recurrence and metastasis rates. Emerging evidence suggests that the NRF2-GPX4 axis is closely associated with ferroptosis. The transcriptional coactivator with PDZ-binding motif (TAZ)
Zhen Song   +5 more
doaj   +1 more source

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway

open access: yesInternational Journal of Biological Sciences
Ubiquitination, a prevalent and highly dynamic reversible post-translational modification, is tightly regulated by the deubiquitinating enzymes (DUBs) superfamily. Among them, OTU Domain-Containing Ubiquitin Aldehyde-Binding Protein 1 (OTUB1) stands out as a critical member of the OTU deubiquitinating family, playing a pivotal role as a tumor regulator
Liao, Yihao   +11 more
openaire   +2 more sources

The Fishermen’s Village: A Case Study of a Bagong Lipunan Improvement of Sites and Services Project in Bago Aplaya, Talomo, Davao City [PDF]

open access: yes
This article is a product of a nine-month training and application program implemented by the micro component of the Economic and Social Impact Analysis/Women in Development (ESIA/WID) and the Food Systems Program of the East-West Center Resource Systems
Conti, Filomena A.
core   +2 more sources

Predicting drug response of tumors from integrated genomic profiles by deep neural networks

open access: yes, 2018
The study of high-throughput genomic profiles from a pharmacogenomics viewpoint has provided unprecedented insights into the oncogenic features modulating drug response.
Chen, Hung-I Harry   +7 more
core   +1 more source

A high stroma-tumor ratio is associated with an immunosuppressive tumor microenvironment and a poor prognosis in bladder cancer

open access: yesFrontiers in Oncology
PurposeBladder cancer (BLCA) is one of the most common urogenital malignancies in the world. The stroma of the tumor microenvironment (TME) largely affects the progression of BLCA.
Yiqiang Da   +7 more
doaj   +1 more source

High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer.

open access: yesInternational journal of clinical and experimental pathology, 2012
To evaluate the association between BLCA-4 tissue expression and patients' prognosis in bladder cancer (BC).BLCA-4 expression was analyzed using immunohistochemical staining methods on tissue samples from a consecutive series of 325 BC patients who underwent resections between 2000 and 2006.
Qian, Zhao   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy